cloudfront

Report Detail



Pharma & HealthcareGlobal Statins Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • RnM2414362
  • |
  • 14 September, 2018
  • |
  • Global
  • |
  • 119 pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Global Statins Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

    1 Market Overview

    • 1.1 Statins Introduction
    • 1.2 Market Analysis by Type
    • 1.2.1 Astrovastatin
  • 1.2.2 Fluvastatin
  • 1.2.3 Lovastatin
  • 1.2.4 Pravastatin
  • 1.2.5 Simvastatin
  • 1.2.6 Others
  • 1.3 Market Analysis by Applications
  • 1.3.1 Hospitals
  • 1.3.2 Clinics
  • 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
  • 1.4.1.1 United States Market States and Outlook (2013-2023)
  • 1.4.1.2 Canada Market States and Outlook (2013-2023)
  • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
  • 1.4.2.1 Germany Market States and Outlook (2013-2023)
  • 1.4.2.2 France Market States and Outlook (2013-2023)
  • 1.4.2.3 UK Market States and Outlook (2013-2023)
  • 1.4.2.4 Russia Market States and Outlook (2013-2023)
  • 1.4.2.5 Italy Market States and Outlook (2013-2023)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • 1.4.3.1 China Market States and Outlook (2013-2023)
  • 1.4.3.2 Japan Market States and Outlook (2013-2023)
  • 1.4.3.3 Korea Market States and Outlook (2013-2023)
  • 1.4.3.4 India Market States and Outlook (2013-2023)
  • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  • 1.4.4 South America, Middle East and Africa
  • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
  • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
  • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
  • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
  • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
  • 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force
  • 2 Manufacturers Profiles

    • 2.1 AstraZeneca
    • 2.1.1 Business Overview
  • 2.1.2 Statins Type and Applications
  • 2.1.2.1 Product A
  • 2.1.2.2 Product B
  • 2.1.3 AstraZeneca Statins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.2 Pfizer
  • 2.2.1 Business Overview
  • 2.2.2 Statins Type and Applications
  • 2.2.2.1 Product A
  • 2.2.2.2 Product B
  • 2.2.3 Pfizer Statins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.3 GlaxoSmithKline
  • 2.3.1 Business Overview
  • 2.3.2 Statins Type and Applications
  • 2.3.2.1 Product A
  • 2.3.2.2 Product B
  • 2.3.3 GlaxoSmithKline Statins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.4 Novartis International
  • 2.4.1 Business Overview
  • 2.4.2 Statins Type and Applications
  • 2.4.2.1 Product A
  • 2.4.2.2 Product B
  • 2.4.3 Novartis International Statins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.5 Merck
  • 2.5.1 Business Overview
  • 2.5.2 Statins Type and Applications
  • 2.5.2.1 Product A
  • 2.5.2.2 Product B
  • 2.5.3 Merck Statins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.6 Biocon
  • 2.6.1 Business Overview
  • 2.6.2 Statins Type and Applications
  • 2.6.2.1 Product A
  • 2.6.2.2 Product B
  • 2.6.3 Biocon Statins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.7 Concord Biotech
  • 2.7.1 Business Overview
  • 2.7.2 Statins Type and Applications
  • 2.7.2.1 Product A
  • 2.7.2.2 Product B
  • 2.7.3 Concord Biotech Statins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.8 Aurobindo Pharma
  • 2.8.1 Business Overview
  • 2.8.2 Statins Type and Applications
  • 2.8.2.1 Product A
  • 2.8.2.2 Product B
  • 2.8.3 Aurobindo Pharma Statins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 3 Global Statins Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    • 3.1 Global Statins Sales and Market Share by Manufacturer (2016-2017)
    • 3.2 Global Statins Revenue and Market Share by Manufacturer (2016-2017)
    • 3.3 Market Concentration Rate
    • 3.3.1 Top 3 Statins Manufacturer Market Share in 2017
  • 3.3.2 Top 6 Statins Manufacturer Market Share in 2017
  • 3.4 Market Competition Trend
  • 4 Global Statins Market Analysis by Regions

    • 4.1 Global Statins Sales, Revenue and Market Share by Regions
    • 4.1.1 Global Statins Sales and Market Share by Regions (2013-2018)
  • 4.1.2 Global Statins Revenue and Market Share by Regions (2013-2018)
  • 4.2 North America Statins Sales and Growth Rate (2013-2018)
  • 4.3 Europe Statins Sales and Growth Rate (2013-2018)
  • 4.4 Asia-Pacific Statins Sales and Growth Rate (2013-2018)
  • 4.5 South America Statins Sales and Growth Rate (2013-2018)
  • 4.6 Middle East and Africa Statins Sales and Growth Rate (2013-2018)
  • 5 North America Statins by Countries

    • 5.1 North America Statins Sales, Revenue and Market Share by Countries
    • 5.1.1 North America Statins Sales and Market Share by Countries (2013-2018)
  • 5.1.2 North America Statins Revenue and Market Share by Countries (2013-2018)
  • 5.2 United States Statins Sales and Growth Rate (2013-2018)
  • 5.3 Canada Statins Sales and Growth Rate (2013-2018)
  • 5.4 Mexico Statins Sales and Growth Rate (2013-2018)
  • 6 Europe Statins by Countries

    • 6.1 Europe Statins Sales, Revenue and Market Share by Countries
    • 6.1.1 Europe Statins Sales and Market Share by Countries (2013-2018)
  • 6.1.2 Europe Statins Revenue and Market Share by Countries (2013-2018)
  • 6.2 Germany Statins Sales and Growth Rate (2013-2018)
  • 6.3 UK Statins Sales and Growth Rate (2013-2018)
  • 6.4 France Statins Sales and Growth Rate (2013-2018)
  • 6.5 Russia Statins Sales and Growth Rate (2013-2018)
  • 6.6 Italy Statins Sales and Growth Rate (2013-2018)
  • 7 Asia-Pacific Statins by Countries

    • 7.1 Asia-Pacific Statins Sales, Revenue and Market Share by Countries
    • 7.1.1 Asia-Pacific Statins Sales and Market Share by Countries (2013-2018)
  • 7.1.2 Asia-Pacific Statins Revenue and Market Share by Countries (2013-2018)
  • 7.2 China Statins Sales and Growth Rate (2013-2018)
  • 7.3 Japan Statins Sales and Growth Rate (2013-2018)
  • 7.4 Korea Statins Sales and Growth Rate (2013-2018)
  • 7.5 India Statins Sales and Growth Rate (2013-2018)
  • 7.6 Southeast Asia Statins Sales and Growth Rate (2013-2018)
  • 8 South America Statins by Countries

    • 8.1 South America Statins Sales, Revenue and Market Share by Countries
    • 8.1.1 South America Statins Sales and Market Share by Countries (2013-2018)
  • 8.1.2 South America Statins Revenue and Market Share by Countries (2013-2018)
  • 8.2 Brazil Statins Sales and Growth Rate (2013-2018)
  • 8.3 Argentina Statins Sales and Growth Rate (2013-2018)
  • 8.4 Colombia Statins Sales and Growth Rate (2013-2018)
  • 9 Middle East and Africa Statins by Countries

    • 9.1 Middle East and Africa Statins Sales, Revenue and Market Share by Countries
    • 9.1.1 Middle East and Africa Statins Sales and Market Share by Countries (2013-2018)
  • 9.1.2 Middle East and Africa Statins Revenue and Market Share by Countries (2013-2018)
  • 9.2 Saudi Arabia Statins Sales and Growth Rate (2013-2018)
  • 9.3 UAE Statins Sales and Growth Rate (2013-2018)
  • 9.4 Egypt Statins Sales and Growth Rate (2013-2018)
  • 9.5 Nigeria Statins Sales and Growth Rate (2013-2018)
  • 9.6 South Africa Statins Sales and Growth Rate (2013-2018)
  • 10 Global Statins Market Segment by Type

    • 10.1 Global Statins Sales, Revenue and Market Share by Type (2013-2018)
    • 10.1.1 Global Statins Sales and Market Share by Type (2013-2018)
  • 10.1.2 Global Statins Revenue and Market Share by Type (2013-2018)
  • 10.2 Astrovastatin Sales Growth and Price
  • 10.2.1 Global Astrovastatin Sales Growth (2013-2018)
  • 10.2.2 Global Astrovastatin Price (2013-2018)
  • 10.3 Fluvastatin Sales Growth and Price
  • 10.3.1 Global Fluvastatin Sales Growth (2013-2018)
  • 10.3.2 Global Fluvastatin Price (2013-2018)
  • 10.4 Lovastatin Sales Growth and Price
  • 10.4.1 Global Lovastatin Sales Growth (2013-2018)
  • 10.4.2 Global Lovastatin Price (2013-2018)
  • 10.5 Pravastatin Sales Growth and Price
  • 10.5.1 Global Pravastatin Sales Growth (2013-2018)
  • 10.5.2 Global Pravastatin Price (2013-2018)
  • 10.6 Simvastatin Sales Growth and Price
  • 10.6.1 Global Simvastatin Sales Growth (2013-2018)
  • 10.6.2 Global Simvastatin Price (2013-2018)
  • 10.7 Others Sales Growth and Price
  • 10.7.1 Global Others Sales Growth (2013-2018)
  • 10.7.2 Global Others Price (2013-2018)
  • 11 Global Statins Market Segment by Application

    • 11.1 Global Statins Sales Market Share by Application (2013-2018)
    • 11.2 Hospitals Sales Growth (2013-2018)
    • 11.3 Clinics Sales Growth (2013-2018)

    12 Statins Market Forecast (2018-2023)

    • 12.1 Global Statins Sales, Revenue and Growth Rate (2018-2023)
    • 12.2 Statins Market Forecast by Regions (2018-2023)
    • 12.2.1 North America Statins Market Forecast (2018-2023)
  • 12.2.2 Europe Statins Market Forecast (2018-2023)
  • 12.2.3 Asia-Pacific Statins Market Forecast (2018-2023)
  • 12.2.4 South America Statins Market Forecast (2018-2023)
  • 12.2.5 Middle East and Africa Statins Market Forecast (2018-2023)
  • 12.3 Statins Market Forecast by Type (2018-2023)
  • 12.3.1 Global Statins Sales Forecast by Type (2018-2023)
  • 12.3.2 Global Statins Market Share Forecast by Type (2018-2023)
  • 12.4 Statins Market Forecast by Application (2018-2023)
  • 12.4.1 Global Statins Sales Forecast by Application (2018-2023)
  • 12.4.2 Global Statins Market Share Forecast by Application (2018-2023)
  • 13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
    • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
  • 13.2 Distributors, Traders and Dealers
  • 14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Statins are special class of drugs that helps in lowering of blood cholesterol level in the body.

      Scope of the Report:

      This report focuses on the Statins in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Rise in prevalence of cholesterol owing to changing lifestyle has led to increased demand for statins worldwide.

      The worldwide market for Statins is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

      Market Segment by Manufacturers, this report covers

      AstraZeneca

      Pfizer

      GlaxoSmithKline

      Novartis International

      Merck

      Biocon

      Concord Biotech

      Aurobindo Pharma

      Market Segment by Regions, regional analysis covers

      North America (United States, Canada and Mexico)

      Europe (Germany, France, UK, Russia and Italy)

      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

      South America (Brazil, Argentina, Colombia etc.)

      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers

      Astrovastatin

      Fluvastatin

      Lovastatin

      Pravastatin

      Simvastatin

      Others

      Market Segment by Applications, can be divided into

      Hospitals

      Clinics

      There are 15 Chapters to deeply display the global Statins market.

      Chapter 1, to describe Statins Introduction, product scope, market overview, market opportunities, market risk, market driving force;

      Chapter 2, to analyze the top manufacturers of Statins, with sales, revenue, and price of Statins, in 2016 and 2017;

      Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

      Chapter 4, to show the global market by regions, with sales, revenue and market share of Statins, for each region, from 2013 to 2018;

      Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

      Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

      Chapter 12, Statins market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

      Chapter 13, 14 and 15, to describe Statins sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source




      Summary:
      Get latest Market Research Reports on Statins . Industry analysis & Market Report on Statins is a syndicated market report, published as Global Statins Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Statins market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,336.82
      3,505.23
      4,673.64
      3,202.30
      4,803.44
      6,404.59
      421,567.20
      632,350.80
      843,134.40
      230,770.63
      346,155.95
      461,541.26
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report